ONCO-IQ Quiz Cup: four days, daily winners, one champion
ABOUT THE ONCO-IQ CUP The ONCO-IQ Cup is a daily clinical knowledge competition running across the 2026 ASCO® Annual Meeting. Quizzes are based on data presented at key oral abstract and plenary sessions throughout the meeting. Top performers each day win prizes, and...
We’re Going to Chicago! Meet ONCOassist at ASCO 2026
We're thrilled to announce that ONCOassist will have its first-ever booth at the American Society of Clinical Oncology (ASCO) Annual Meeting 2026. Join us in Chicago this May/June and see how we're transforming clinical decision support for oncology healthcare...
ONCOassist Launches ONCO-IQ: A Quiz-Based Learning Feature Bringing Interactivity to Oncology Education
[et_pb_text content_tablet="Your go-to digest for the latest breakthroughs in cancer care. From breakthrough PARP/AR combo efficacy to transformative immunotherapy approvals and rare cancer strides, this week’s oncology updates spotlight how precision therapies and...
Weekly Oncology Highlights | Oncology News, Updates and Spotlights
[et_pb_text content_tablet="Your go-to digest for the latest breakthroughs in cancer care. From breakthrough PARP/AR combo efficacy to transformative immunotherapy approvals and rare cancer strides, this week’s oncology updates spotlight how precision therapies and...
Weekly Oncology Highlights | Oncology News, Updates and Spotlights
[et_pb_text content_tablet="Your go-to digest for the latest breakthroughs in cancer care. From breakthrough PARP/AR combo efficacy to transformative immunotherapy approvals and rare cancer strides, this week’s oncology updates spotlight how precision therapies and...
Weekly Oncology Highlights | Oncology News, Updates and Spotlights
[et_pb_text content_tablet="Your go-to digest for the latest breakthroughs in cancer care. From breakthrough PARP/AR combo efficacy to transformative immunotherapy approvals and rare cancer strides, this week’s oncology updates spotlight how precision therapies and...
Weekly Oncology Highlights – Powered by ONCOassist
[et_pb_text content_tablet="Your go-to digest for the latest breakthroughs in cancer care. From breakthrough PARP/AR combo efficacy to transformative immunotherapy approvals and rare cancer strides, this week’s oncology updates spotlight how precision therapies and...
Weekly Oncology Highlights – Powered by ONCOassist
Your go-to digest for the latest breakthroughs in cancer care.  From a landmark EU approval of perioperative immunotherapy in bladder cancer to strong CAR‑T durability and promising oral regimens in haematological malignancies, this week’s oncology updates show how...
Weekly Oncology Highlights – Powered by ONCOassist
Your go-to digest for the latest breakthroughs in cancer care. Â From targeted therapies to regulatory shifts, these five developments highlight how precision oncology is reshaping standards of care, empowering clinicians with new tools and broader accessibility....
A Quick Guide to Oncology Starter Packs on Bluesky: A Resource for Oncology Professionals
In the fast-paced world of oncology, staying informed and connected is crucial. Bluesky, a rising platform for professionals, offers a growing number of starter packs tailored to oncology professionals, providing quick access to resources and communities. Whether...
Issue 3 – Key updates from the world of Geriatric oncology
April 2019 Below are key updates in Geriatric oncology from the last 5 weeks, curated by Dr. Lorenzo Dottorini. 1. Using Implementation Science to Promote the Use of the G8 Screening Tool in Geriatric Oncology Pauline Gulasingam MBBS et al Journal of American...
March issue – Key updates from the world of Geriatric oncology
By Dr. Lorenzo Dottorini 1. Predicting chemotherapy toxicity in older adults: Comparing the predictive value of the CARG Toxicity Score with oncologists' estimates of toxicity based on clinical judgement Erin B. Moth et al. Journal of Geriatric Oncology...
Updates in Geriatric oncology
March 2019 Below are key updates in Geriatric oncology from the last 5 weeks, curated by Dr. Lorenzo Dottorini. 1.Patient- and tumor-related predictors of chemotherapy intolerance in older patients with cancer: A systematic review. van Abbema DL, van den Akker M,...
ONCOassist now delivered to 20,000 oncology nurses throughout Europe
Killarney, February 7th 2017: Irish Medical Device Company, Portable Medical Technology, has finalized a partnership with the European Oncology Nursing Society to make it’s flagship product, ONCOassist available to over 20,000 oncology nurses throughout Europe....
Mobilising Hospital Guidelines and Protocols – Every CMO’s Dream
Hospitals and staff operate in a controlled environment where guidelines and protocols are in place. These guidelines and protocols are essential to every hospital as they provide frameworks for working with multi-discipline teams and allow NHS staff to put a...
Integrate or die! The future of mhealth.
Healthcare IT has long been dominated by large institutional players; these larger vendors had the capacity to withstand the long sales cycles and large up front development costs. However, they have not had the same incentives to integrate and partner as smaller...
ONCOassist deployed in The Clatterbridge Cancer Centre as Enterprise system
Portable Medical Technology and The Clatterbridge Cancer Centre NHS Foundation Trust have today announced an enterprise agreement which will see ONCOassist, Portable Medical Technology’s revolutionary CE approved software system being deployed as the main oncology decision support system used within Clatterbridge.